# REVIEW PENDING: Morpheus8 — Clinical Dossier
**Product:** InMode Morpheus8  
**Product ID:** 84ac561e-1818-4ece-a8d7-1fb6c5ea80df  
**Category:** RF Microneedling (836bcdf0)  
**Plan:** 02-05  
**Status:** draft — awaiting provider review

## Documents in This Review

| doc_id | lens | doc_type | title |
|--------|------|----------|-------|
| b1e2a3f4-5c6d-7e8f-9a0b-1c2d3e4f5a6b | clinical | clinical_summary | Morpheus8 — Clinical Summary |
| c2d3e4f5-6a7b-8c9d-0e1f-2a3b4c5d6e7f | clinical | technique_guide | Morpheus8 — Technique Guide |

## Key Clinical Claims to Verify

1. **FDA Clearance:** Subdermal adipose tissue remodeling + skin resurfacing [InMode 510k K192271] — verify clearance wording matches current 510k
2. **Fitzpatrick Safety:** "Insulated needle shafts limit epidermal thermal exposure, significantly reducing PIH risk for darker skin types" — clinical reviewer should confirm this claim is appropriately characterized (not overstated)
3. **Depth Range:** 0.5–8mm (face 4mm, body 8mm) — verify against current Morpheus8 tip specifications
4. **Combination Sequencing:** "Energy first, filler 2–4 weeks later" — verify this matches practice consensus at your clinic
5. **PIH Risk — Mandatory Disclosure:** The clinical summary includes a mandatory Fitzpatrick documentation requirement — confirm this is aligned with your practice SOPs

## Reviewer Instructions

- Clinical reviewer: provider with RF microneedling experience
- Mark any clinical claims that require stronger evidence citation
- Verify combination sequencing matches your practice's informed consent language
- Approve each document individually; clinical_summary requires higher bar

## Approval Actions

To approve: UPDATE agent_reference_docs SET status = 'active', approved_by = '[reviewer]', approved_at = now() WHERE id = '[doc_id]';
